Literature DB >> 16541271

[Giant cell arteritis (temporal arteritis). Pathophysiology, immunology].

A D Wagner1.   

Abstract

The diagnosis of giant cell arteritis is established by temporal artery biopsy. The findings are those of a panarteritis with mononuclear infiltrates penetrating all layers of the arterial wall. Typically, activated T cells and macrophages are arranged in granulomas. Multinucleated giant cells, when present, are usually close to the fragmented internal elastic lamina. Often, the intimal layer is hyperplastic, leading to concentric occlusion of the lumen. The CD4(+) T cells are the main players in the disease process. T-cell activation in the arterial wall requires the presence of specialized antigen-presenting cells, the dendritic cells. The activation of monocytes and macrophages is responsible for the systemic inflammatory syndrome in giant cell arteritis and polymyalgia rheumatica. The blood vessel wall determines the site specificity of giant cell arteritis and provides the ground for the cell to cell interaction.

Entities:  

Mesh:

Year:  2006        PMID: 16541271     DOI: 10.1007/s00347-006-1327-6

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  39 in total

1.  A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease?

Authors:  E B Machado; S E Gabriel; C M Beard; C J Michet; W M O'Fallon; D J Ballard
Journal:  Int J Epidemiol       Date:  1989-12       Impact factor: 7.196

Review 2.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

3.  Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease.

Authors:  A D Wagner; J J Goronzy; C M Weyand
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

4.  Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology.

Authors:  A D Wagner; J Björnsson; G B Bartley; J J Goronzy; C M Weyand
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

5.  Hepatitis-B antibody in polymyalgia Rheumatica.

Authors:  P A Bacon; S M Doherty; A J Zuckerman
Journal:  Lancet       Date:  1975-09-13       Impact factor: 79.321

6.  Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis.

Authors:  N E Roche; J W Fulbright; A D Wagner; G G Hunder; J J Goronzy; C M Weyand
Journal:  Arthritis Rheum       Date:  1993-09

7.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

Authors:  T Y Chuang; G G Hunder; D M Ilstrup; L T Kurland
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

8.  Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association.

Authors:  A Dababneh; M A Gonzalez-Gay; C Garcia-Porrua; A Hajeer; W Thomson; W Ollier
Journal:  J Rheumatol       Date:  1998-11       Impact factor: 4.666

9.  Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis.

Authors:  J T Lie
Journal:  Arthritis Rheum       Date:  1990-08
View more
  2 in total

Review 1.  The diagnosis and treatment of giant cell arteritis.

Authors:  Thomas Ness; Thorsten A Bley; Wolfgang A Schmidt; Peter Lamprecht
Journal:  Dtsch Arztebl Int       Date:  2013-05-24       Impact factor: 5.594

Review 2.  [Vasculitis: histopathology and differential diagnosis].

Authors:  K Holl-Ulrich; F Noack; A C Feller
Journal:  Z Rheumatol       Date:  2009-06       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.